|
FDA approves new treatment for HIV
|
06 November 2015 |
|
FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa
|
19 October 2015 |
|
FDA approves new injectable drug to treat schizophrenia
|
09 October 2015 |
|
FDA approves Keytruda for advanced non-small cell lung cancer
|
05 October 2015 |
|
FDA approves first treatment for sexual desire disorder
|
19 August 2015 |
|
FDA takes action to protect consumers from potentially dangerous counterfeit medicines and devices sold online
|
03 July 2015 |
|
FDA approves anti-clotting drug Savaysa
|
15 January 2015 |
|
FDA warns consumers about fraudulent Ebola treatment products
|
14 August 2014 |
|
FDA issues guidance to support the responsible development of nanotechnology products
|
25 June 2014 |
|
FDA launches openFDA to provide easy access to valuable FDA public data
|
13 June 2014 |
|
FDA requires removal of certain restrictions on the diabetes drug Avandia
|
26 November 2013 |
|
FDA approves new drug to treat HIV infection
|
15 August 2013 |
|
FDA alerts companies to stop illegal sale of treatments for diabetes
|
23 July 2013 |
|
FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies
|
27 June 2013 |
|
FDA obtains waiver from European Commission to facilitate export for U.S. pharmaceutical manufacturers
|
23 June 2013 |
|
FDA budget requests $4.7 billion
|
11 April 2013 |
|
FDA alerts health care providers of recall of anemia drug Omontys
|
24 February 2013 |
|
FDA approves Pomalyst for advanced multiple myeloma
|
10 February 2013 |
|
FDA approves Gleevec for children with acute lymphoblastic leukemia
|
27 January 2013 |
|
FDA approves new seasonal influenza vaccine made using novel technology
|
16 January 2013 |